Johnson & Johnson

NYSE:JNJ   10:23:55 AM EDT
171.27
-0.91 (-0.53%)
Products

Janssen Submits New Drug Application To U.S. FDA For XARELTO

Published: 06/23/2021 13:22 GMT
Johnson & Johnson (JNJ) - Janssen Submits New Drug Application to U.S. FDA for Xarelto® (rivaroxaban) to Help Prevent and Treat Blood Clots in Pediatric Patients.
Janssen - NDA Seeks 2 Pediatric Indications, Including an Age-appropriate New Weight-based Oral Suspension Formulation to Help Minimize Dosing Errors.